Vaccines train the immune system to recognise a specific infection before a person encounters it. They are among the most closely monitored medical products, but no medicine is completely free from adverse effects. Recommendations are based on evidence about benefits and risks for particular ages, health conditions and exposure patterns.
How vaccination creates protection
A vaccine presents the immune system with an antigen—or instructions for producing one—without causing the full disease it is designed to prevent. Immune cells respond and develop memory. If the person later meets the pathogen, the response can be faster and more effective.
Different platforms include live attenuated, inactivated, protein-based, viral-vector and mRNA vaccines. The most suitable approach depends on the infection, target population and evidence from research.
From laboratory research to clinical trials
- Preclinical research studies the candidate in laboratory systems and often animals.
- Early clinical trials assess initial safety, dose and immune response in a small number of volunteers.
- Larger trials examine safety and whether vaccination prevents disease or another defined outcome.
- Regulatory review evaluates quality, manufacturing, safety and effectiveness data.
- Post-authorisation monitoring continues after widespread use and can identify rare adverse events.
Trial phases can overlap or proceed quickly when funding, recruitment and regulatory work occur efficiently. This does not remove the required evaluation of evidence.
Effectiveness is not all-or-nothing
A vaccine may be very effective at preventing severe disease while offering less protection against mild infection or transmission. Protection can change over time, as pathogens evolve and immunity wanes. This is why recommendations may include additional doses for some groups.
Safety monitoring
Common reactions such as pain at the injection site, fatigue or a mild fever are usually short-lived. Serious adverse events are uncommon, and an event occurring after vaccination is not necessarily caused by it. Researchers compare observed events with expected background rates and use multiple data systems to investigate safety signals.
Recommendations may change when new evidence changes the balance of benefits and risks. This is a normal part of continuous safety monitoring, not evidence that no assessment occurred.
Who should seek individual advice?
Ask a healthcare professional about vaccination if you have had a severe allergic reaction to a previous dose or ingredient, are pregnant, have a weakened immune system, take immune-suppressing treatment or are acutely unwell. The correct advice depends on the specific vaccine and your circumstances.
Evaluating vaccine claims
- Check whether a claim comes from a public-health authority or peer-reviewed research.
- Distinguish a reported event from a proven side effect.
- Look for absolute risks, the comparison group and study size.
- Be cautious with anecdotes presented as proof.
- Use the vaccination schedule and advice for your country.
This article provides general information. Vaccination decisions should follow current local recommendations and individual medical advice.
Sources
- World Health Organization: What Is Vaccination?
- World Health Organization: Vaccines and Immunization
- US CDC: Explaining How Vaccines Work
- European Medicines Agency: Vaccines
Last reviewed: 28 August 2026